Met kinase homology model with its inhibitor, SU11271, docked in the ATP binding site. The cover image was selected from an article previously published in Molecular Cancer Therapeutics, which was chosen in celebration of the 10^th anniversary of the journal. For details, see the commentary by Wang and colleagues on page 2022.